LUPLUSMEA

Swiss trademark · 748401 · Word mark · In force

Register entry

Registration number
748401
Application number
01569/2020
Status
In force
Type
Word mark
Filed
Feb 6, 2020
Registered
Jun 16, 2020
Published
Jun 16, 2020
Protected until
Feb 6, 2030
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le diagnostic et le traitement de maladies et de troubles oncologiques; préparations pharmaceutiques destinées à accroître l'efficacité d'autres produits pharmaceutiques dans le traitement de maladies oncologiques; agents d'administration de médicaments consistant en des composés facilitant l'administration d'une large gamme de produits pharmaceutiques pour traiter les cancers.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 8, 2022

    Transferred

    Owner
    Endocyte, Inc., 3000 Kent Avenue, Suite A1-100, West Lafayette, IN 47906-1075, USA → NOVARTIS AG, 4002 Basel

    Published in Swissreg on 08.02.2022

  2. Oct 28, 2020

    Agent removed

    Representative
    Kirker & Cie SA, Case Postale 153, Rue de Genève 122, 1226 Thônex (removed)

    Published in Swissreg on 28.10.2020

  3. Jun 16, 2020

    Registered

    Published in Swissreg on 16.06.2020

Parties

Holder

Novartis AG

NOVARTIS AG

4002 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.